Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: milestone / Re: correction / Re: BUSHleague /

Perhaps, but:

"In the first quarter of the 2006 fiscal year we entered into an agreement with Intel Corporation licensing our intellectual property, in connection with which we received a one-time payment of $10,000,000."

http://www.sec.gov/Archives/edgar/da...

This post dates any commentary you cite here. Similar language was used in describing all of the other licenses reported prior to the adoption of the PDS Financials reporting method that leaves everything lumped together. Also, Leckrones comments at the SHM about one-time payments and not being setup for royalties postdated the comments you cite.

1
May 01, 2008 05:59AM

May 01, 2008 07:05AM
2
May 01, 2008 07:17AM
1
May 01, 2008 07:58AM
Share
New Message
Please login to post a reply